Anastasis biosensor
AssigneeThe Johns Hopkins University
InventorsDenise Montell, Ho Lam Tang
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Johns Hopkins University
InventorsDenise Montell, Ho Lam Tang
Estimating the term…
The present invention relates to the field of anastasis, i.e., the process of reversal of apoptosis. More specifically, the present invention provides methods and compositions useful for studying anastasis. In one embodiment, the present invention provides an in vivo biosensor comprising (a) a transcription factor complex comprising the Gal4 transcription factor linked to an enzyme cleavable linker, wherein the transcription factor complex is tethered to the plasma membrane via a transmembrane domain; and (b) a reporter system comprising (1) a first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; and (2) a second nucleic acid comprising an FRT-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame.
An in vivo biosensor comprising:
6-9. (canceled)
A biosensor system comprising:
A biosensor system comprising:
16-19. (canceled)
A biosensor comprising a nucleic acid comprising a stop codon cassette flanked by site specific recombinase recombination sequences, wherein the stop codon cassette and flanking sequences separate a constitutive promoter and a fluorescent protein open reading frame.
Dependencies are inferred from the claim text.